India · Delayed Price · Currency is INR TTK Healthcare Statistics
Total Valuation
TTK Healthcare has a market cap or net worth of INR 12.45 billion. The enterprise value is 6.36 billion.
| Market Cap | 12.45B |
| Enterprise Value | 6.36B |
Important Dates
The last earnings date was Saturday, May 30, 2026.
| Earnings Date | May 30, 2026 |
| Ex-Dividend Date | Jul 17, 2026 |
Share Statistics
TTK Healthcare has 14.13 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 14.13M |
| Shares Outstanding | 14.13M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 8.31% |
| Owned by Institutions (%) | 4.28% |
| Float | 3.25M |
Valuation Ratios
The trailing PE ratio is 18.96.
| PE Ratio | 18.96 |
| Forward PE | n/a |
| PS Ratio | 1.45 |
| PB Ratio | 1.12 |
| P/TBV Ratio | 1.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 9.68 |
| EV / Sales | 0.74 |
| EV / EBITDA | 24.29 |
| EV / EBIT | 36.51 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.91, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.91 |
| Quick Ratio | 3.61 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.93 |
| Debt / FCF | -0.90 |
| Interest Coverage | 5.95 |
Financial Efficiency
Return on equity (ROE) is 6.03% and return on invested capital (ROIC) is 2.73%.
| Return on Equity (ROE) | 6.03% |
| Return on Assets (ROA) | 0.83% |
| Return on Invested Capital (ROIC) | 2.73% |
| Return on Capital Employed (ROCE) | 1.55% |
| Weighted Average Cost of Capital (WACC) | 5.80% |
| Revenue Per Employee | 6.40M |
| Profits Per Employee | 490,519 |
| Employee Count | 1,339 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 3.71 |
Taxes
In the past 12 months, TTK Healthcare has paid 168.83 million in taxes.
| Income Tax | 168.83M |
| Effective Tax Rate | 20.45% |
Stock Price Statistics
The stock price has decreased by -31.12% in the last 52 weeks. The beta is 0.27, so TTK Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -31.12% |
| 50-Day Moving Average | 890.85 |
| 200-Day Moving Average | 1,010.58 |
| Relative Strength Index (RSI) | 46.03 |
| Average Volume (20 Days) | 153 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TTK Healthcare had revenue of INR 8.57 billion and earned 656.81 million in profits. Earnings per share was 46.48.
| Revenue | 8.57B |
| Gross Profit | 4.54B |
| Operating Income | 174.16M |
| Pretax Income | 825.63M |
| Net Income | 656.81M |
| EBITDA | 261.76M |
| EBIT | 174.16M |
| Earnings Per Share (EPS) | 46.48 |
Balance Sheet
The company has 6.33 billion in cash and 243.78 million in debt, with a net cash position of 6.09 billion or 431.05 per share.
| Cash & Cash Equivalents | 6.33B |
| Total Debt | 243.78M |
| Net Cash | 6.09B |
| Net Cash Per Share | 431.05 |
| Equity (Book Value) | 11.15B |
| Book Value Per Share | 788.93 |
| Working Capital | 10.12B |
Cash Flow
In the last 12 months, operating cash flow was -211.48 million and capital expenditures -58.02 million, giving a free cash flow of -269.51 million.
| Operating Cash Flow | -211.48M |
| Capital Expenditures | -58.02M |
| Depreciation & Amortization | 87.60M |
| Net Borrowing | -5.95M |
| Free Cash Flow | -269.51M |
| FCF Per Share | -19.07 |
Margins
Gross margin is 52.93%, with operating and profit margins of 2.03% and 7.66%.
| Gross Margin | 52.93% |
| Operating Margin | 2.03% |
| Pretax Margin | 9.63% |
| Profit Margin | 7.66% |
| EBITDA Margin | 3.05% |
| EBIT Margin | 2.03% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.00, which amounts to a dividend yield of 1.12%.
| Dividend Per Share | 10.00 |
| Dividend Yield | 1.12% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 21.51% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 1.11% |
| Earnings Yield | 5.28% |
| FCF Yield | -2.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |